- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
According to this latest study, the 2020 growth of Dermatology OTC Medications will have significant change from previous year. By the most conservative estimates of global Dermatology OTC Medications market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 11730 million in 2019. Over the next five years the Dermatology OTC Medications market will register a 3.4% CAGR in terms of revenue, the global market size will reach US$ 13400 million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Dermatology OTC Medications market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
External Use
Oral
The classification of dermatology OTC medications includes external use, oral and the proportion of external use in 2019 is about 93%.
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospital
Drug Store
Other
Dermatology OTC medications is widely used in hospital, drug store and other field. The most proportion of dermatology OTC medications is drug store, and the proportion in 2019 is 58.2%.
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Bayer
GSK
Teva
Johnson & Johnson
Novartis
Mylan
Sun Pharmaceutical
Aurobindo
Galderma
CR SANJIU
Dr. Reddy's
Lupin
Bausch Health
Cipla
Qilu Pharmaceutical
Almirall
Lingrui
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Dermatology OTC Medications Consumption 2016-2026
2.1.2 Dermatology OTC Medications Consumption CAGR by Region
2.2 Dermatology OTC Medications Segment by Type
2.2.1 External Use
2.2.2 Oral
2.3 Dermatology OTC Medications Sales by Type
2.3.1 Global Dermatology OTC Medications Sales Market Share by Type (2016-2021)
2.3.2 Global Dermatology OTC Medications Revenue and Market Share by Type (2016-2021)
2.3.3 Global Dermatology OTC Medications Sale Price by Type (2016-2021)
2.4 Dermatology OTC Medications Segment by Application
2.4.1 Hospital
2.4.2 Drug Store
2.4.3 Other
2.5 Dermatology OTC Medications Sales by Application
2.5.1 Global Dermatology OTC Medications Sale Market Share by Application (2016-2021)
2.5.2 Global Dermatology OTC Medications Revenue and Market Share by Application (2016-2021)
2.5.3 Global Dermatology OTC Medications Sale Price by Application (2016-2021)
3 Global Dermatology OTC Medications by Company
3.1 Global Dermatology OTC Medications Sales Market Share by Company
3.1.1 Global Dermatology OTC Medications Sales by Company (2019-2021)
3.1.2 Global Dermatology OTC Medications Sales Market Share by Company (2019-2021)
3.2 Global Dermatology OTC Medications Revenue Market Share by Company
3.2.1 Global Dermatology OTC Medications Revenue by Company (2019-2021)
3.2.2 Global Dermatology OTC Medications Revenue Market Share by Company (2019-2021)
3.3 Global Dermatology OTC Medications Sale Price by Company
3.4 Global Manufacturers Dermatology OTC Medications Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Dermatology OTC Medications Product Location Distribution
3.4.2 Players Dermatology OTC Medications Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Dermatology OTC Medications by Region
4.1 Global Dermatology OTC Medications by Region
4.1.1 Global Dermatology OTC Medications Sales by Region
4.1.2 Global Dermatology OTC Medications Revenue by Region
4.2 Americas Dermatology OTC Medications Sales Growth
4.3 APAC Dermatology OTC Medications Sales Growth
4.4 Europe Dermatology OTC Medications Sales Growth
4.5 Middle East & Africa Dermatology OTC Medications Sales Growth
5 Americas
5.1 Americas Dermatology OTC Medications Sales by Country
5.1.1 Americas Dermatology OTC Medications Sales by Country (2016-2021)
5.1.2 Americas Dermatology OTC Medications Revenue by Country (2016-2021)
5.2 Americas Dermatology OTC Medications Sales by Type
5.3 Americas Dermatology OTC Medications Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dermatology OTC Medications Sales by Region
6.1.1 APAC Dermatology OTC Medications Sales by Region (2016-2021)
6.1.2 APAC Dermatology OTC Medications Revenue by Region (2016-2021)
6.2 APAC Dermatology OTC Medications Sales by Type
6.3 APAC Dermatology OTC Medications Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Dermatology OTC Medications by Country
7.1.1 Europe Dermatology OTC Medications Sales by Country (2016-2021)
7.1.2 Europe Dermatology OTC Medications Revenue by Country (2016-2021)
7.2 Europe Dermatology OTC Medications Sales by Type
7.3 Europe Dermatology OTC Medications Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Dermatology OTC Medications by Country
8.1.1 Middle East & Africa Dermatology OTC Medications Sales by Country (2016-2021)
8.1.2 Middle East & Africa Dermatology OTC Medications Revenue by Country (2016-2021)
8.2 Middle East & Africa Dermatology OTC Medications Sales by Type
8.3 Middle East & Africa Dermatology OTC Medications Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Dermatology OTC Medications Distributors
10.3 Dermatology OTC Medications Customer
11 Global Dermatology OTC Medications Market Forecast
11.1 Global Dermatology OTC Medications Forecast by Region
11.1.1 Global Dermatology OTC Medications Forecast by Regions (2021-2026)
11.2.2 Global Dermatology OTC Medications Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Dermatology OTC Medications Forecast by Type
11.7 Global Dermatology OTC Medications Forecast by Application
12 Key Players Analysis
12.1 Bayer
12.1.1 Bayer Bayer Company Information
12.1.2 Bayer Dermatology OTC Medications Product Offered
12.1.3 Bayer Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Bayer Main Business Overview
12.1.5 Bayer Latest Developments
12.2 GSK
12.2.1 GSK Company Information
12.2.2 GSK Dermatology OTC Medications Product Offered
12.2.3 GSK Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 GSK Main Business Overview
12.2.5 GSK Latest Developments
12.3 Teva
12.3.1 Teva Company Information
12.3.2 Teva Dermatology OTC Medications Product Offered
12.3.3 Teva Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Teva Main Business Overview
12.3.5 Teva Latest Developments
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Company Information
12.4.2 Johnson & Johnson Dermatology OTC Medications Product Offered
12.4.3 Johnson & Johnson Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Johnson & Johnson Main Business Overview
12.4.5 Johnson & Johnson Latest Developments
12.5 Novartis
12.5.1 Novartis Company Information
12.5.2 Novartis Dermatology OTC Medications Product Offered
12.5.3 Novartis Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Novartis Main Business Overview
12.5.5 Novartis Latest Developments
12.6 Mylan
12.6.1 Mylan Company Information
12.6.2 Mylan Dermatology OTC Medications Product Offered
12.6.3 Mylan Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Mylan Main Business Overview
12.6.5 Mylan Latest Developments
12.7 Sun Pharmaceutical
12.7.1 Sun Pharmaceutical Company Information
12.7.2 Sun Pharmaceutical Dermatology OTC Medications Product Offered
12.7.3 Sun Pharmaceutical Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Sun Pharmaceutical Main Business Overview
12.7.5 Sun Pharmaceutical Latest Developments
12.8 Aurobindo
12.8.1 Aurobindo Company Information
12.8.2 Aurobindo Dermatology OTC Medications Product Offered
12.8.3 Aurobindo Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Aurobindo Main Business Overview
12.8.5 Aurobindo Latest Developments
12.9 Galderma
12.9.1 Galderma Company Information
12.9.2 Galderma Dermatology OTC Medications Product Offered
12.9.3 Galderma Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Galderma Main Business Overview
12.9.5 Galderma Latest Developments
12.10 CR SANJIU
12.10.1 CR SANJIU Company Information
12.10.2 CR SANJIU Dermatology OTC Medications Product Offered
12.10.3 CR SANJIU Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 CR SANJIU Main Business Overview
12.10.5 CR SANJIU Latest Developments
12.11 Dr. Reddy's
12.11.1 Dr. Reddy's Company Information
12.11.2 Dr. Reddy's Dermatology OTC Medications Product Offered
12.11.3 Dr. Reddy's Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Dr. Reddy's Main Business Overview
12.11.5 Dr. Reddy's Latest Developments
12.12 Lupin
12.12.1 Lupin Company Information
12.12.2 Lupin Dermatology OTC Medications Product Offered
12.12.3 Lupin Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Lupin Main Business Overview
12.12.5 Lupin Latest Developments
12.13 Bausch Health
12.13.1 Bausch Health Company Information
12.13.2 Bausch Health Dermatology OTC Medications Product Offered
12.13.3 Bausch Health Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Bausch Health Main Business Overview
12.13.5 Bausch Health Latest Developments
12.14 Cipla
12.14.1 Cipla Company Information
12.14.2 Cipla Dermatology OTC Medications Product Offered
12.14.3 Cipla Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Cipla Main Business Overview
12.14.5 Cipla Latest Developments
12.15 Qilu Pharmaceutical
12.15.1 Qilu Pharmaceutical Company Information
12.15.2 Qilu Pharmaceutical Dermatology OTC Medications Product Offered
12.15.3 Qilu Pharmaceutical Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Qilu Pharmaceutical Main Business Overview
12.15.5 Qilu Pharmaceutical Latest Developments
12.16 Almirall
12.16.1 Almirall Company Information
12.16.2 Almirall Dermatology OTC Medications Product Offered
12.16.3 Almirall Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 Almirall Main Business Overview
12.16.5 Almirall Latest Developments
12.17 Lingrui
12.17.1 Lingrui Company Information
12.17.2 Lingrui Dermatology OTC Medications Product Offered
12.17.3 Lingrui Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2019-2021)
12.17.4 Lingrui Main Business Overview
12.17.5 Lingrui Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Dermatology OTC Medications Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of External Use
Table 3. Major Players of Oral
Table 4. Global Dermatology OTC Medications Sales by Type (2016-2021) & (M Units)
Table 5. Global Dermatology OTC Medications Sales Market Share by Type (2016-2021)
Table 6. Global Dermatology OTC Medications Revenue by Type (2016-2021) & ($ million)
Table 7. Global Dermatology OTC Medications Revenue Market Share by Type (2016-2021)
Table 8. Global Dermatology OTC Medications Sale Price by Type (2016-2021)
Table 9. Global Dermatology OTC Medications Sales by Application (2016-2021) & (M Units)
Table 10. Global Dermatology OTC Medications Sales Market Share by Application (2016-2021)
Table 11. Global Dermatology OTC Medications Value by Application (2016-2021)
Table 12. Global Dermatology OTC Medications Revenue Market Share by Application (2016-2021)
Table 13. Global Dermatology OTC Medications Sale Price by Application (2016-2021)
Table 14. Global Dermatology OTC Medications Sales by Company (2019-2021) & (M Units)
Table 15. Global Dermatology OTC Medications Sales Market Share by Company (2019-2021)
Table 16. Global Dermatology OTC Medications Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Dermatology OTC Medications Revenue Market Share by Company (2019-2021)
Table 18. Global Dermatology OTC Medications Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Dermatology OTC Medications Producing Area Distribution and Sales Area
Table 20. Players Dermatology OTC Medications Products Offered
Table 21. Dermatology OTC Medications Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Dermatology OTC Medications Sales by Region (2016-2021) (M Units)
Table 25. Global Dermatology OTC Medications Sales Market Share by Region (2016-2021)
Table 26. Global Dermatology OTC Medications Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Dermatology OTC Medications Revenue Market Share by Region (2016-2021)
Table 28. Americas Dermatology OTC Medications Sales by Country (2016-2021) & (M Units)
Table 29. Americas Dermatology OTC Medications Sales Market Share by Country (2016-2021)
Table 30. Americas Dermatology OTC Medications Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Dermatology OTC Medications Revenue Market Share by Country (2016-2021)
Table 32. Americas Dermatology OTC Medications Sales by Type (2016-2021) & (M Units)
Table 33. Americas Dermatology OTC Medications Sales Market Share by Type (2016-2021)
Table 34. Americas Dermatology OTC Medications Sales by Application (2016-2021) & (M Units)
Table 35. Americas Dermatology OTC Medications Sales Market Share by Application (2016-2021)
Table 36. APAC Dermatology OTC Medications Sales by Region (2016-2021) & (M Units)
Table 37. APAC Dermatology OTC Medications Sales Market Share by Region (2016-2021)
Table 38. APAC Dermatology OTC Medications Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Dermatology OTC Medications Revenue Market Share by Region (2016-2021)
Table 40. APAC Dermatology OTC Medications Sales by Type (2016-2021) & (M Units)
Table 41. APAC Dermatology OTC Medications Sales Market Share by Type (2016-2021)
Table 42. APAC Dermatology OTC Medications Sales by Application (2016-2021) & (M Units)
Table 43. APAC Dermatology OTC Medications Sales Market Share by Application (2016-2021)
Table 44. Europe Dermatology OTC Medications Sales by Country (2016-2021) & (M Units)
Table 45. Europe Dermatology OTC Medications Sales Market Share by Country (2016-2021)
Table 46. Europe Dermatology OTC Medications Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Dermatology OTC Medications Revenue Market Share by Country (2016-2021)
Table 48. Europe Dermatology OTC Medications Sales by Type (2016-2021) & (M Units)
Table 49. Europe Dermatology OTC Medications Sales Market Share by Type (2016-2021)
Table 50. Europe Dermatology OTC Medications Sales by Application (2016-2021) & (M Units)
Table 51. Europe Dermatology OTC Medications Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Dermatology OTC Medications Sales by Country (2016-2021) & (M Units)
Table 53. Middle East & Africa Dermatology OTC Medications Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Dermatology OTC Medications Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Dermatology OTC Medications Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Dermatology OTC Medications Sales by Type (2016-2021) & (M Units)
Table 57. Middle East & Africa Dermatology OTC Medications Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Dermatology OTC Medications Sales by Application (2016-2021) & (M Units)
Table 59. Middle East & Africa Dermatology OTC Medications Sales Market Share by Application (2016-2021)
Table 60. Global Dermatology OTC Medications Sales Forecast by Type (2021-2026) & (M Units)
Table 61. Global Dermatology OTC Medications Sales Market Share Forecast by Type (2021-2026)
Table 62. Global Dermatology OTC Medications Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 63. Global Dermatology OTC Medications Revenue Market Share Forecast by Type (2021-2026)
Table 64. Global Dermatology OTC Medications Sales Forecast by Application (2021-2026) & (M Units)
Table 65. Global Dermatology OTC Medications Sales Market Share Forecast by Application (2021-2026)
Table 66. Global Dermatology OTC Medications Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 67. Global Dermatology OTC Medications Revenue Market Share Forecast by Application (2021-2026)
Table 68. Bayer Basic Information, Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 69. Bayer Dermatology OTC Medications Product Offered
Table 70. Bayer Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 71. Bayer Main Business
Table 72. Bayer Latest Developments
Table 73. GSK Basic Information, Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 74. GSK Dermatology OTC Medications Product Offered
Table 75. GSK Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 76. GSK Main Business
Table 77. GSK Latest Developments
Table 78. Teva Basic Information, Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 79. Teva Dermatology OTC Medications Product Offered
Table 80. Teva Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 81. Teva Main Business
Table 82. Teva Latest Developments
Table 83. Johnson & Johnson Basic Information, Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 84. Johnson & Johnson Dermatology OTC Medications Product Offered
Table 85. Johnson & Johnson Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 86. Johnson & Johnson Main Business
Table 87. Johnson & Johnson Latest Developments
Table 88. Novartis Basic Information, Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 89. Novartis Dermatology OTC Medications Product Offered
Table 90. Novartis Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 91. Novartis Main Business
Table 92. Novartis Latest Developments
Table 93. Mylan Basic Information, Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 94. Mylan Dermatology OTC Medications Product Offered
Table 95. Mylan Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 96. Mylan Main Business
Table 97. Mylan Latest Developments
Table 98. Sun Pharmaceutical Basic Information, Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 99. Sun Pharmaceutical Dermatology OTC Medications Product Offered
Table 100. Sun Pharmaceutical Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 101. Sun Pharmaceutical Main Business
Table 102. Sun Pharmaceutical Latest Developments
Table 103. Aurobindo Basic Information, Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 104. Aurobindo Dermatology OTC Medications Product Offered
Table 105. Aurobindo Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 106. Aurobindo Main Business
Table 107. Aurobindo Latest Developments
Table 108. Galderma Basic Information, Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 109. Galderma Dermatology OTC Medications Product Offered
Table 110. Galderma Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 111. Galderma Main Business
Table 112. Galderma Latest Developments
Table 113. CR SANJIU Basic Information, Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 114. CR SANJIU Dermatology OTC Medications Product Offered
Table 115. CR SANJIU Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 116. CR SANJIU Main Business
Table 117. CR SANJIU Latest Developments
Table 118. Dr. Reddy's Basic Information, Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 119. Dr. Reddy's Dermatology OTC Medications Product Offered
Table 120. Dr. Reddy's Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 121. Dr. Reddy's Main Business
Table 122. Dr. Reddy's Latest Developments
Table 123. Lupin Basic Information, Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 124. Lupin Dermatology OTC Medications Product Offered
Table 125. Lupin Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 126. Lupin Main Business
Table 127. Lupin Latest Developments
Table 128. Bausch Health Basic Information, Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 129. Bausch Health Dermatology OTC Medications Product Offered
Table 130. Bausch Health Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 131. Bausch Health Main Business
Table 132. Bausch Health Latest Developments
Table 133. Cipla Basic Information, Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 134. Cipla Dermatology OTC Medications Product Offered
Table 135. Cipla Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 136. Cipla Main Business
Table 137. Cipla Latest Developments
Table 138. Qilu Pharmaceutical Basic Information, Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 139. Qilu Pharmaceutical Dermatology OTC Medications Product Offered
Table 140. Qilu Pharmaceutical Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 141. Qilu Pharmaceutical Main Business
Table 142. Qilu Pharmaceutical Latest Developments
Table 143. Almirall Basic Information, Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 144. Almirall Dermatology OTC Medications Product Offered
Table 145. Almirall Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 146. Almirall Main Business
Table 147. Almirall Latest Developments
Table 148. Lingrui Basic Information, Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 149. Lingrui Dermatology OTC Medications Product Offered
Table 150. Lingrui Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 151. Lingrui Main Business
Table 152. Lingrui Latest Developments
List of Figures
Figure 1. Picture of Dermatology OTC Medications
Figure 2. Dermatology OTC Medications Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Dermatology OTC Medications Sales Growth Rate 2016-2026 (M Units)
Figure 7. Global Dermatology OTC Medications Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Dermatology OTC Medications Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of External Use
Figure 10. Product Picture of Oral
Figure 11. Global Dermatology OTC Medications Sales Market Share by Type in 2020
Figure 12. Global Dermatology OTC Medications Revenue Market Share by Type (2016-2021)
Figure 13. Dermatology OTC Medications Consumed in Hospital
Figure 14. Global Dermatology OTC Medications Market: Hospital (2016-2021) & (M Units)
Figure 15. Dermatology OTC Medications Consumed in Drug Store
Figure 16. Global Dermatology OTC Medications Market: Drug Store (2016-2021) & (M Units)
Figure 17. Dermatology OTC Medications Consumed in Other
Figure 18. Global Dermatology OTC Medications Market: Other (2016-2021) & (M Units)
Figure 19. Global Dermatology OTC Medications Sales Market Share by Application (2016-2021)
Figure 20. Global Dermatology OTC Medications Revenue Market Share by Application in 2020
Figure 21. Global Dermatology OTC Medications Revenue Market by Company in 2020 ($ Million)
Figure 22. Global Dermatology OTC Medications Revenue Market Share by Company in 2020
Figure 23. Global Dermatology OTC Medications Sales Market Share by Regions (2016-2021)
Figure 24. Global Dermatology OTC Medications Revenue Market Share by Region in 2020
Figure 25. Americas Dermatology OTC Medications Sales 2016-2021 (M Units)
Figure 26. Americas Dermatology OTC Medications Revenue 2016-2021 ($ Millions)
Figure 27. APAC Dermatology OTC Medications Sales 2016-2021 (M Units)
Figure 28. APAC Dermatology OTC Medications Revenue 2016-2021 ($ Millions)
Figure 29. Europe Dermatology OTC Medications Sales 2016-2021 (M Units)
Figure 30. Europe Dermatology OTC Medications Revenue 2016-2021 ($ Millions)
Figure 31. Middle East & Africa Dermatology OTC Medications Sales 2016-2021 (M Units)
Figure 32. Middle East & Africa Dermatology OTC Medications Revenue 2016-2021 ($ Millions)
Figure 33. Americas Dermatology OTC Medications Sales Market Share by Country in 2020
Figure 34. Americas Dermatology OTC Medications Revenue Market Share by Country in 2020
Figure 35. Americas Dermatology OTC Medications Sales Market Share by Type in 2020
Figure 36. Americas Dermatology OTC Medications Sales Market Share by Application in 2020
Figure 37. United States Dermatology OTC Medications Revenue Growth 2016-2021 ($ Millions)
Figure 38. Canada Dermatology OTC Medications Revenue Growth 2016-2021 ($ Millions)
Figure 39. Mexico Dermatology OTC Medications Revenue Growth 2016-2021 ($ Millions)
Figure 40. Brazil Dermatology OTC Medications Revenue Growth 2016-2021 ($ Millions)
Figure 41. APAC Dermatology OTC Medications Sales Market Share by Region in 2020
Figure 42. APAC Dermatology OTC Medications Revenue Market Share by Regions in 2020
Figure 43. APAC Dermatology OTC Medications Sales Market Share by Type in 2020
Figure 44. APAC Dermatology OTC Medications Sales Market Share by Application in 2020
Figure 45. China Dermatology OTC Medications Revenue Growth 2016-2021 ($ Millions)
Figure 46. Japan Dermatology OTC Medications Revenue Growth 2016-2021 ($ Millions)
Figure 47. Korea Dermatology OTC Medications Revenue Growth 2016-2021 ($ Millions)
Figure 48. Southeast Asia Dermatology OTC Medications Revenue Growth 2016-2021 ($ Millions)
Figure 49. India Dermatology OTC Medications Revenue Growth 2016-2021 ($ Millions)
Figure 50. Australia Dermatology OTC Medications Revenue Growth 2016-2021 ($ Millions)
Figure 51. Europe Dermatology OTC Medications Sales Market Share by Country in 2020
Figure 52. Europe Dermatology OTC Medications Revenue Market Share by Country in 2020
Figure 53. Europe Dermatology OTC Medications Sales Market Share by Type in 2020
Figure 54. Europe Dermatology OTC Medications Sales Market Share by Application in 2020
Figure 55. Germany Dermatology OTC Medications Revenue Growth 2016-2021 ($ Millions)
Figure 56. France Dermatology OTC Medications Revenue Growth 2016-2021 ($ Millions)
Figure 57. UK Dermatology OTC Medications Revenue Growth 2016-2021 ($ Millions)
Figure 58. Italy Dermatology OTC Medications Revenue Growth 2016-2021 ($ Millions)
Figure 59. Russia Dermatology OTC Medications Revenue Growth 2016-2021 ($ Millions)
Figure 60. Middle East & Africa Dermatology OTC Medications Sales Market Share by Country in 2020
Figure 61. Middle East & Africa Dermatology OTC Medications Revenue Market Share by Country in 2020
Figure 62. Middle East & Africa Dermatology OTC Medications Sales Market Share by Type in 2020
Figure 63. Middle East & Africa Dermatology OTC Medications Sales Market Share by Application in 2020
Figure 64. Egypt Dermatology OTC Medications Revenue Growth 2016-2021 ($ Millions)
Figure 65. South Africa Dermatology OTC Medications Revenue Growth 2016-2021 ($ Millions)
Figure 66. Israel Dermatology OTC Medications Revenue Growth 2016-2021 ($ Millions)
Figure 67. Turkey Dermatology OTC Medications Revenue Growth 2016-2021 ($ Millions)
Figure 68. GCC Country Dermatology OTC Medications Revenue Growth 2016-2021 ($ Millions)
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
Please feel free to write an email to us or to use our electronic ticketing system.
